235 related articles for article (PubMed ID: 31419741)
21. A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking.
Zhang Z; Zhang ZS; Wang X; Xi GL; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2087-2103. PubMed ID: 34823417
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial Activity and Pharmacokinetic Profile of a Promising Antibacterial Agent: 22-(2-Amino-phenylsulfanyl)-22-Deoxypleuromutilin.
Zuo X; Fang X; Zhang Z; Jin Z; Xi G; Liu Y; Tang Y
Molecules; 2020 Feb; 25(4):. PubMed ID: 32079232
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin.
Zuo XY; Gao H; Gao ML; Jin Z; Tang YZ
Molecules; 2021 Jun; 26(12):. PubMed ID: 34201372
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel pleuromutilin derivatives as potent antibacterial agents.
Zhou Y; Yi Y; Wang J; Yang Z; Liu Q; Pu W; Shang R
Eur J Med Chem; 2022 Jul; 237():114403. PubMed ID: 35472849
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.
Li YG; Wang JX; Zhang GN; Zhu M; You XF; Wang YC; Zhang F
Bioorg Med Chem Lett; 2020 Apr; 30(7):126969. PubMed ID: 32014384
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
[TBL] [Abstract][Full Text] [Related]
29. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.
Xu P; Zhang YY; Sun YX; Liu JH; Yang B; Wang YZ; Wang YL
Chem Biol Drug Des; 2009 Jun; 73(6):655-60. PubMed ID: 19635057
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antibacterial activities of novel pleuromutilin derivatives.
Yi Y; Fu Y; Wang K; Shui Y; Cai J; Jia Z; Niu B; Liang J; Shang R
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800155. PubMed ID: 30058185
[TBL] [Abstract][Full Text] [Related]
31. In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant
Hu Y; Chen F; Zhou K; Zhang Z; Li F; Zhang J; Tang Y; Jin Z
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956888
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety.
Yi Y; Xu X; Liu Y; Xu S; Huang X; Liang J; Shang R
Eur J Med Chem; 2017 Jan; 126():687-695. PubMed ID: 27940400
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring.
Luo J; Yang QE; Yang YY; Tang YZ; Liu YH
Chem Biol Drug Des; 2016 Nov; 88(5):699-709. PubMed ID: 27273921
[TBL] [Abstract][Full Text] [Related]
35. A click chemistry approach to pleuromutilin derivatives. Part 3: extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chain.
Dreier I; Hansen LH; Nielsen P; Vester B
Bioorg Med Chem Lett; 2014 Feb; 24(4):1043-6. PubMed ID: 24486133
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of 3-(4-halophenyl)-3-oxopropanal and their derivatives as novel antibacterial agents.
Liu J; Yi W; Hu J; Wu F; Zhao L; Song H; Wang Z
Chem Pharm Bull (Tokyo); 2010 Sep; 58(9):1127-31. PubMed ID: 20823588
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of pleuromutilin derivatives containing 1,2,4-triazole linker.
Zhou ZD; Hu YH; Wang Q; Xu H; Xi GL; Liu Y; Gu L; Jin Z; Tang YZ
Drug Dev Res; 2023 Jun; 84(4):703-717. PubMed ID: 36896715
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.
Deng Y; Zhang Y; Chen XH; Li CH
Eur J Med Chem; 2023 Jan; 246():114960. PubMed ID: 36462445
[TBL] [Abstract][Full Text] [Related]
39. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
